Swing Therapeutics, Inc. — Form D
Swing Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-29. The offering totals $14.6M, of which $11.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2025-08-29
- Form: D
- Accession: 0001786195-25-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $14.6M
- Amount sold: $11.4M
- Remaining: $3.2M
- Investors: 14
- Date of first sale: 2025-05-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-556228
Issuer
- Name: Swing Therapeutics, Inc.
- CIK: 0001786195
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 548 MARKET STREET, #63989, SAN FRANCISCO, CA, 94104
- Phone: 000-000-0000
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Corey McCann | Director | Boston, MA |
| Michael Rosenbluth | Director | San Francisco, CA |
| Michael Rosenbluth | Executive Officer | San Francisco, CA |
| Andrew Firlik | Director | Rowayton, CT |
| Zack Lynch | Director | San Francisco, CA |
Other filings by this issuer (3)
More